Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Chow

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
Cancer Chemotherapy and Pharmacology|November 22, 2017
Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult menRichard Markus, Vincent Chow, Zhiying Pan, et al.
Clinical Pharmacology in Drug Development|July 7, 2023
Pharmacokinetic Similarity of ABP 654, an Ustekinumab Biosimilar Candidate: Results from a Randomized, Double-blind Study in Healthy SubjectsVincent Chow, Daniel T Mytych, Shyamal Das, et al.
Clinical Pharmacology in Drug Development|October 20, 2019
Pharmacokinetic Similarity of ABP 710, a Proposed Biosimilar to Infliximab: Results From a Randomized, Single-Blind, Single-Dose, Parallel-Group Study in Healthy SubjectsVincent Chow, MyungShin Oh, Melissa A Gessner, et al.
Biotechnology Progress|April 22, 2008
Identifying inhibitory threshold values of repressing metabolites in CHO cell culture using multivariate analysis methodsZizhuo Xing, Zhengjian Li, Vincent Chow, et al.
Heart, Lung & Circulation|April 13, 2019
Incidence and Impact of Hypoalbuminaemia on Outcomes Following Acute Pulmonary EmbolismScott Hoskin, Vincent Chow, Leonard Kritharides, et al.
Journal of Clinical Pharmacology|September 14, 2013
Pharmacokinetics of tofacitinib, a janus kinase inhibitor, in patients with impaired renal function and end-stage renal diseaseSriram Krishnaswami, Vincent Chow, Mary Boy, et al.
European Journal of Haematology|March 21, 2020
A randomized, double-blind, single-dose, three-arm, parallel group study to determine pharmacokinetic similarity of ABP 959 and eculizumab (Soliris<sup>®</sup> ) in healthy male subjectsVincent Chow, Jean Pan, David Chien, et al.
Thrombosis and Haemostasis|February 28, 2021
Trends in Acute Pulmonary Embolism Admission Rates and Mortality Outcomes in Australia, 2002-2003 to 2017-2018: A Retrospective Cohort StudyScott Hoskin, David Brieger, Vincent Chow, et al.
British Journal of Clinical Pharmacology|March 18, 2010
Co-administration of the JAK inhibitor CP-690,550 and methotrexate is well tolerated in patients with rheumatoid arthritis without need for dose adjustmentStanley Cohen, Samuel H Zwillich, Vincent Chow, et al.
Cardiovascular Ultrasound|June 4, 2013
Right atrial to left atrial area ratio on early echocardiography predicts long-term survival after acute pulmonary embolismVincent Chow, Austin Chin Chwan Ng, Tommy Chung, et al.
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Cancer Chemotherapy and Pharmacology|November 22, 2017
Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult menRichard Markus, Vincent Chow, Zhiying Pan, et al.
Clinical Pharmacology in Drug Development|July 7, 2023
Pharmacokinetic Similarity of ABP 654, an Ustekinumab Biosimilar Candidate: Results from a Randomized, Double-blind Study in Healthy SubjectsVincent Chow, Daniel T Mytych, Shyamal Das, et al.
Clinical Pharmacology in Drug Development|October 20, 2019
Pharmacokinetic Similarity of ABP 710, a Proposed Biosimilar to Infliximab: Results From a Randomized, Single-Blind, Single-Dose, Parallel-Group Study in Healthy SubjectsVincent Chow, MyungShin Oh, Melissa A Gessner, et al.
Biotechnology Progress|April 22, 2008
Identifying inhibitory threshold values of repressing metabolites in CHO cell culture using multivariate analysis methodsZizhuo Xing, Zhengjian Li, Vincent Chow, et al.
Heart, Lung & Circulation|April 13, 2019
Incidence and Impact of Hypoalbuminaemia on Outcomes Following Acute Pulmonary EmbolismScott Hoskin, Vincent Chow, Leonard Kritharides, et al.
Journal of Clinical Pharmacology|September 14, 2013
Pharmacokinetics of tofacitinib, a janus kinase inhibitor, in patients with impaired renal function and end-stage renal diseaseSriram Krishnaswami, Vincent Chow, Mary Boy, et al.
European Journal of Haematology|March 21, 2020
A randomized, double-blind, single-dose, three-arm, parallel group study to determine pharmacokinetic similarity of ABP 959 and eculizumab (Soliris<sup>®</sup> ) in healthy male subjectsVincent Chow, Jean Pan, David Chien, et al.
Thrombosis and Haemostasis|February 28, 2021
Trends in Acute Pulmonary Embolism Admission Rates and Mortality Outcomes in Australia, 2002-2003 to 2017-2018: A Retrospective Cohort StudyScott Hoskin, David Brieger, Vincent Chow, et al.
British Journal of Clinical Pharmacology|March 18, 2010
Co-administration of the JAK inhibitor CP-690,550 and methotrexate is well tolerated in patients with rheumatoid arthritis without need for dose adjustmentStanley Cohen, Samuel H Zwillich, Vincent Chow, et al.
Cardiovascular Ultrasound|June 4, 2013
Right atrial to left atrial area ratio on early echocardiography predicts long-term survival after acute pulmonary embolismVincent Chow, Austin Chin Chwan Ng, Tommy Chung, et al.
Pageof 11